Homayoon BASHIRI, Arezoo BOZORGOMID, Vahıd SHOJAEIMOTLAGH

Efficacy of Hijamat wet cupping therapy in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial

Background/aim: Nonalcoholic fatty liver disease NAFLD is known to be the most prevalent chronic liver disease all over the world. The incidence of this disease has dramatically increased during the last decade. Studies have shown a strong relationship between the level of ferritin and the severity of NAFLD. The objective of the present study was to assess the effect of adding Hijamat, as an iron reducing procedure, to standard lifestyle modification on the improvement of insulin resistance and liver enzymes in patients with NAFLD. Materials and methods: One hundred and twenty NAFLD patients participated in a randomized, controlled, single-blind trial design of study. The control group received counselling for nutrition and physical activity for a period of 6 months. The treatment group received the above items plus Hijamat for 3 times during 1 month. Ultrasound images of liver, HOMA-IR, and laboratory data including ALT, AST were assessed pre- and postintervention. Results: At the end of the study, a significant decrease was demonstrated in the serum level of HOMA-IR -1.30 ± 0.88 vs -.02 ± 0.47, P

Keywords:

Nonalcoholic fatty liver disease, wet cupping Hijamat, ALT, AST,

PDF

___

1. Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World Journal of Hepatology 2017; 9 (16): 715-732. doi: 10.4254/wjh.v9.i16.715
2. Bellentani S. The epidemiology of non‐alcoholic fatty liver disease. Liver International 2017; 37: 81-84. doi: 10.1111/ liv.13299
3. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical Gastroenterology and Hepatology 2011; 9 (6):524-530. doi: 10.1016/j.cgh.2011.03.020
4. van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AI, Arends JE. A Review of non-alcoholic fatty liver disease in HIV-infected patients: the next big thing? Infectious Diseases and Therapy 2019; 8 (1):33-50. doi: 10.1007/s40121-018-0229- 7
5. Esser N, Legrand-Poels S, Piette J, Paquot N, Scheen A. NLRP3 inflammasome and visceral adipose tissue. Revue Médicale de Liège 2014, 69: 57-61.
6. Sara Al-Rawi, Michael D Fetters. Traditional arabic & islamic medicine: a conceptual model for clinicians and researchers. Global Journal of Health Science 2012; 4 (3): 164-169. doi: 10.5539/gjhs.v4n3p164
7. El Sayed S, Mahmoud H, Nabo M. Methods of wet cupping therapy (Al-Hijamah): in light of modern medicine and prophetic medicine. Alternative & Integrative Medicine 2013: 1-16.
8. Valenti L, Moscatiello S, Vanni E, Fracanzani A, Bugianesi E et al. Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling—a propensity scoreadjusted observational study. Monthly Journal of the Association of Physicians 2011; 104 (2): 141-149. doi: 10.1093/ qjmed/hcq170
9. Khodadoostan M, Zamanidoost M, Shavakhi A, Sanei H, Shahbazi M et al. Effects of phlebotomy on liver enzymes and histology of patients with nonalcoholic fatty liver disease. Advanced Biomedical Research 2017; 6: 12. doi: 10.4103/2277- 9175.200787
10. El Sayed SM, Abou-Taleb A, Mahmoud HS, Baghdadi H, Maria RA et al. Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia. Medical Hypotheses 2014; 83 (2): 238-246. doi: 10.1016/j.mehy.2014.04.001
11. Ahmadi A, Schwebel DC, Rezaei M. The efficacy of wetcupping in the treatment of tension and migraine headache. The American Journal of Chinese Medicine 2008; 36 (1): 37- 44.
12. Hertzog MA. Considerations in determining sample size for pilot studies. Research in Nursing & Health 2008; 31 (2): 180- 191. doi: 10.1002/nur.20247
13. Mihmanli I, Kantarci F, Yilmaz MH, Gurses B, Selcuk D et al. Effect of diffuse fatty infiltration of the liver on hepatic artery resistance index. Journal of Clinical Ultrasound 2005; 33 (3): 95- 99.
14. Shah RA, Kowdley KV. Serum ferritin as a biomarker for NAFLD: ready for prime time? Hepatology International 2019; 13 (2): 110-112. doi: 10.1007/s12072-019-09934-7
15. Valenti L, Dongiovanni P, Fargion S. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. World Journal of Gastroenterol 2012; 18 (29): 3782-3786.
16. El-Shanshory M, Hablas NM, Shebl Y, Fakhreldin AR, Attia M et al. Al-hijamah (wet cupping therapy of prophetic medicine) significantly and safely reduces iron overload and oxidative stress in thalassemic children: a novel pilot study. Journal of Blood Medicine 2018; 9: 241-251. doi: 10.2147/JBM.S170523
17. Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxidative Medicine and Cellular Longevity 2018; 2018: 9547613. doi: 10.1155/2018/9547613
18. Suhaily MH, Ismail A-S, Aziz A, Najib MY. Randomized control trial study on the effect of wet cupping on lipid profile. International Medical Journal Malaysia 2017; 16 (2): 11-17.
19. Fattahi N, Sharifi K, Moradi G, Iri R, Reshadat R et al. Prevalence of non-alcoholic fatty liver disease in Kurdistan Province, Iran, 2013-2014: a population based study. Govaresh 2018; 23 (2): 109- 116.
20. Mahaling DU, Basavaraj MM, Bika AJ. Comparison of lipid profile in different grades of non-alcoholic fatty liver disease diagnosed on ultrasound. Asian Pacific Journal of Tropical Biomedicine 2013; 3 (11): 907-912. doi: 10.1016/S2221-1691(13)60177-X
21. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. The American Journal of Gastroenterology 2007; 102 (6): 1251-1258.
22. Al-Bedah AM, Shaban T, Suhaibani A, Gazzaffi I, Khalil M et al. Safety of cupping therapy in studies conducted in twenty one century: a review of literature. British Journal of Medicine and Medical Research 2016; 15 (8): 1-12.
23. Nimrouzi M, Mahbodi A, Jaladat A-M, Sadeghfard A, Zarshenas MM. Hijamat in traditional Persian medicine: risks and benefits. Journal of Evidence-Based Complementary & Alternative Medicine 2014; 19 (2): 128-136. doi: 10.1177/2156587214524578
24. Harrison SA, Day CP. Benefits of lifestyle modification in NAFLD. Gut 2007; 56 (12): 1760-1769.
25. Nseir W, Hellou E, Assy N. Role of diet and lifestyle changes in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20 (28): 9338-9344. doi: 10.3748/wjg. v20.i28.9338